Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells-Reference-Cited by-同舟云学术

Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells

Published:2017-05-08 Issue:30 Volume:8 Page:49451-49469
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Salati Simona¹,Salvestrini Valentina²,Carretta Chiara¹,Genovese Elena¹,Rontauroli Sebastiano¹,Zini Roberta¹,Rossi Chiara¹,Ruberti Samantha¹,Bianchi Elisa¹,Barbieri Greta¹,Curti Antonio²,Castagnetti Fausto²,Gugliotta Gabriele²,Rosti Gianantonio²,Bergamaschi Micaela³,Tafuri Agostino⁴,Tagliafico Enrico⁵,Lemoli Roberto³,Manfredini Rossella¹

Affiliation:

1. Center for Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy

2. Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology “L. and A. Seràgnoli”, University of Bologna, S.Orsola-Malpighi Hospital, Bologna, Italy

3. Department of Internal Medicine (DiMI), Clinic of Hematology, University of Genoa, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genoa, Italy

4. Department of Clinical and Molecular Medicine, Clinic of Hematology, University “La Sapienza”, Rome, Italy

5. Center for Genome Research, University of Modena and Reggio Emilia, Modena, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signaling pathways governing the behaviors of leukemia stem cells;Genes & Diseases;2024-03

2. Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors;Expert Opinion on Pharmacotherapy;2024-01-22

3. Role of miRNAs to control the progression of Chronic Myeloid Leukemia by their expression levels;Medical Oncology;2024-01-12

4. JAK1 Is a Novel Target of Tumor- and Invasion-Suppressive microRNA 494-5p in Colorectal Cancer;Cancers;2023-12-20

5. Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia;International Journal of Molecular Sciences;2023-11-23